<table border="1" cellpadding="2" cellspacing="1" width="500" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td valign="bottom">
<content stylecode="bold"></content>Concomitant Drug </td>
<td valign="bottom">Effect on Concentration of Lamotrigine or Concomitant Drug </td>
<td valign="bottom">Clinical Comment </td>
</tr>
<tr>
<td rowspan="2" valign="top">Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel </td>
<td valign="top">↓ lamotrigine </td>
<td valign="top">Decreased lamotrigine levels approximately 50%. </td>
</tr>
<tr>
<td colspan="1" valign="top">↓levonorgestrel </td>
<td colspan="1" valign="top">Decrease in levonorgestrel component by 19%. </td>
</tr>
<tr>
<td colspan="1" rowspan="2" valign="top">Carbamazepine (CBZ) and CBZ epoxide </td>
<td valign="top">↓ lamotrigine </td>
<td valign="top">Addition of carbamazepine decreases lamotrigine concentration approximately 40%. </td>
</tr>
<tr>
<td colspan="1" valign="top">? CBZ epoxide </td>
<td colspan="1" valign="top">May increase CBZ epoxide levels </td>
</tr>
<tr>
<td valign="top">Phenobarbital/Primidone </td>
<td valign="top">↓ lamotrigine </td>
<td valign="top">Decreased lamotrigine concentration approximately 40%. </td>
</tr>
<tr>
<td valign="top">Phenytoin (PHT) </td>
<td valign="top">↓ lamotrigine </td>
<td valign="top">Decreased lamotrigine concentration approximately 40%. </td>
</tr>
<tr>
<td valign="top">Rifampin </td>
<td valign="top">↓ lamotrigine </td>
<td valign="top">Decreased lamotrigine AUC approximately 40%. </td>
</tr>
<tr>
<td rowspan="2" valign="top">Valproate </td>
<td valign="top">↑ lamotrigine </td>
<td valign="top">Increased lamotrigine concentrations slightly more than 2-fold. </td>
</tr>
<tr>
<td colspan="1" valign="top">? valproate </td>
<td colspan="1" valign="top">Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients. </td>
</tr>
</tbody>
</table>